Thanks Crash, The British are pragmatic and they will approve a new therapy with efficacy and no side effects... Dc Vax had groundbreaking trial results and it has the potential for even more amazing eficacy with combination of polyi icl and or maybe keytruda. Britian was smart not to fund the helmet and their sketchy survival data. And I think the money is there for Nice approvoal but I believe it has to be coordinated with flashworks approvoal. Its all about being able to meet the demand. And nwbo is counting on manufacturing approvoal for the new device in Britian first. Good luck friends!
Market Data 
Markets 
AI
